01.EMMS - General Pharmacology 1
01.EMMS - General Pharmacology 1
01.EMMS - General Pharmacology 1
General Pharmacology I
Dr. Faisal Alamri
Assistant Professor of pharmaceutical Sciences
[email protected]
@faisalfahd0
Basic Pharmacology Block
PDNT/PMED.PMSC/PPHR -213
Credit: Dr. Wesam Saleh 1
LECTURE OBJECTIVES
• Pharmacokinetics
– …
• Pharmacodynamics
– …
Drug Development
• In vitro Studies: Isolate/synthesize a lead compound (a candidate drug);
vary and optimize
• Marketing: Patents expire in 15-20 years (varies with country) – after that,
generic drugs tend to take out market share
Drug Development
Drug Names
• Chemical name:
– benzeneacetamide, 4-[2'-hydroxy-3'-[(1-
methylethyl)amino]propoxy]-.
– C14H22N2O3.
• Brand Name
– Tenormin
2. The Toxic Dose: the amount of a drug that will produce noxious
(harmful) effects.
3. The Lethal Dose of a drug is the amount of substance (a drug) that
will cause death (
– the term "LD50" is usually associated with the lethal dose, which means that
50% of the animals given that amount of drug died.
Drug Doses
Oral Transdermal
Topical
Properties of Ideal Drug
• 1. Reversible action
– Effects be reversible, i.e., removal/subside w/i specific time
(1/2 life is short but potent during that time)
– Example: General Anesthetic; Contraceptives
• 2. Predictability
– Know how patient will respond
• 3. Ease of Administration
– Number of doses should be low and easy to administer why?
– 1. increase compliance & 2. decrease errors
• Diabetic patient: Multiple daily injection of insulin
• Intravenous infusion
Additional Properties of an Ideal Drug
• 5. Low Cost
– Easy to afford (especially with chronic illness)
• Growth hormone (somatrem) costs between $10,000 and $20,000
• Lifelong medication: hypertension, arthritis, diabetes
Additional Properties of an Ideal Drug
• 6. Chemical Stability
– No lose of effectiveness with storage
• Prescription
AGONIST ANTAGONIST
Noradrenaline Salbutamol
Isoprenaline
Examples of Antagonists
Non-selective β
Prazosin blockers
Atenolol
Second Messenger System
Adenylate Cyclase
Inactive
Second Messenger System
Adenylate Cyclase
Activates
Second Messenger System
Adenylate Cyclase
Part of G-Protein
activates Adenylate
Cyclase
Second Messenger System
Activated
Adenylate Cyclase
ATP cAMP
Factors that determine
Intensity of Drug Response
2. Pharmacokinetic processes
• Determines how much of an administered dose gets to its sites
of action (absorption, distribution, metabolism, excretion)
3. Pharmacodynamics
• Once a drug has reached its site of action, pharmacodynamic
processes determine the type of response and intensity